Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Aarti Pharmalabs Financial Results

Aarti Pharmalabs reported its FY26 audited financial results and recommended a final dividend of Rs. 2 per share. The board also re-appointed cost and internal auditors.

Key figures
Value₹2.00 Cr
Source

NSE filing, NSE: AARTIPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Aarti Pharmalabs Ltd: key numbers

Share price
₹881.95
Market cap
₹7,998 Cr
Revenue (annual)
₹1,819 Cr
Net profit (annual)
₹174.7 Cr
P/E (TTM)
37.5×Sector 46.1×
Promoter holding
39.66%-3.20% QoQ
FII holding
8.16%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aarti Pharmalabs Ltd

All →

Other financial results announcements

All →